21 terminated. 21 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 21 | Terminated 21 |
| Phase 1 | 4 | Terminated 4 |
Follow Sunitinib malate: new trials by email Literature Review of Sunitinib malate trials Research Report on Sunitinib malate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population Sunitinib malate - Renal Cell Carcinoma | Phase 2 | Terminated | vghtpe user | 13 | 2015-08-12 | 2018-06-26 |
| Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia Antitumor Drug Screening Assay, Dasatinib, Idelalisib - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | Terminated | OHSU Knight Cancer Institute | 12 | 2012-05-11 | 2021-11-04 |
| Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma Everolimus, Sunitinib - Kidney Cancer | Phase 2 | Terminated | M.D. Anderson Cancer Center | 73 | 2010-08-01 | 2021-04-28 |
| Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients sunitinib malate, docetaxel, prednisone - Prostate Cancer, Adenocarcinoma of the Prostate | Phase 1 / Phase 2 | Terminated | John P. Fruehauf | 4 | 2009-07-01 | 2017-02-01 |
| Sunitinib Malate in Refractory Germ Cell Tumors Sunitinib Malate - Genitourinary Disease | Phase 2 | Terminated | M.D. Anderson Cancer Center | 5 | 2009-05-01 | 2016-04-15 |
| Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases sunitinib malate, cognitive assessment - Cognitive/Functional Effects, Metastatic Cancer | Phase 2 | Terminated | Case Comprehensive Cancer Center | 14 | 2009-04-01 | 2014-09-29 |
| Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC Gemcitabine, Cisplatin, Sunitinib Malate - Transitional Cell Carcinoma of the Bladder | Phase 2 | Terminated | Noah Hahn, M.D. | 9 | 2009-03-01 | 2016-04-14 |
| Sunitinib Malate in Treating Patients With Small Cell Lung Cancer sunitinib malate, laboratory biomarker analysis, fludeoxyglucose F 18 - Lung Cancer | Phase 2 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 9 | 2009-02-01 | 2018-07-26 |
| Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow sunitinib malate, flow cytometry, immunohistochemistry staining method - Breast Cancer | Phase 2 | Terminated | University of California, San Francisco | 13 | 2009-02-01 | 2018-04-05 |
| Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer therapeutic allogeneic lymphocytes, sunitinib malate - Kidney Cancer | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 10 | 2009-02-01 | 2021-04-27 |
| Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer sunitinib malate, immunohistochemistry staining method, TdT-mediated dUTP nick end labeling assay - Recurrent Bladder Cancer, Transitional Cell Carcinoma of the Bladder | Phase 2 | Terminated | Case Comprehensive Cancer Center | 19 | 2008-10-01 | 2019-05-01 |
| Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer sunitinib malate, capecitabine - Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Terminated | University of Washington | 41 | 2008-09-01 | 2017-06-01 |
| Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome Sunitinib Malate - Von Hippel-Lindau Syndrome | Phase 1 / Phase 2 | Terminated | National Eye Institute (NEI) | 2 | 2008-05-01 | 2024-01-05 |
| A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer exemestane, sunitinib malate - Breast Neoplasms | Phase 1 / Phase 2 | Terminated | Pfizer | 6 | 2007-06-01 | 2010-09-21 |
| Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery doxorubicin hydrochloride, sunitinib malate, laboratory biomarker analysis - Liver Cancer | Phase 2 | Terminated | Roswell Park Cancer Institute | 16 | 2007-04-01 | 2017-05-09 |
| Sunitinib in Certain Subtypes of Soft Tissue Sarcomas Sunitinib - Sarcoma, Soft Tissue | Phase 2 | Terminated | Columbia University | 10 | 2007-04-01 | 2019-11-04 |
| Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma cyclophosphamide, lenalidomide, sunitinib malate - Intraocular Melanoma, Malignant Conjunctival Neoplasm | Phase 2 | Terminated | National Institutes of Health Clinical Center (CC) | 12 | 2007-04-01 | 2017-03-27 |
| Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) Sunitinib Malate - Liver Cancer | Phase 2 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 33 | 2006-10-01 | 2012-03-27 |
| Sunitinib in Treating Patients With Idiopathic Myelofibrosis sunitinib malate - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 14 | 2006-09-01 | 2014-05-28 |
| Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow SU011248 - Von Hippel-Lindau Syndrome, Renal Cell Carcinoma | Phase 2 | Terminated | M.D. Anderson Cancer Center | 15 | 2006-05-01 | 2024-06-27 |
Showing 20 of 21. Sign in to see all of them.
Carcinoma, Renal Cell (4) · Breast Neoplasms (3) · Carcinoma, Hepatocellular (2) · Kidney Neoplasms (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Liver Neoplasms (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · von Hippel-Lindau Disease (2) · Blast Crisis (1) · Brain Neoplasms (1) · Breast Neoplasms, Male (1) · Congenital Abnormalities (1) · Cysts (1) · Hemangioblastoma (1)
M.D. Anderson Cancer Center (3) · Case Comprehensive Cancer Center (2) · University of California, San Francisco (2) · Columbia University (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · John P. Fruehauf (1) · National Cancer Institute (NCI) (1) · National Eye Institute (NEI) (1) · National Institutes of Health Clinical Center (CC) (1) · Noah Hahn, M.D. (1) · OHSU Knight Cancer Institute (1) · Pfizer (1) · Roswell Park Cancer Institute (1) · Rutgers, The State University of New Jersey (1)
United States (18) · Canada (1) · Netherlands (1) · Taiwan (1) · United Kingdom (1)
Hope S. Rugo, MD (2) · Amado Zurita, MD (1) · Catherine Meyerle, MD (1) · David M. Peereboom, MD (1) · Egbert F. Smit, MD (1) · Eric Jonasch, MD (1) · John P Fruehauf, MD, PhD (1) · Jonathan Strosberg, MD (1) · Jorge Garcia, MD (1) · Lance Pagliaro, MD, BA (1) · Marc Loriaux (1) · Noah Hahn, M.D. (1) · Renuka Iyer, MD (1) · Robert N Taub, MD, PhD (1)
PMID 22105611, PMID 23228446, PMID 25085632, PMID 31231785
N01CM62202 (1), P30CA043703 (1), P30CA072720 (1), R21CA159265 (1)